BOCIC(SH:601696) Xin Lang Cai Jing·2025-09-02 06:02Company Overview - Zhixiang Jintai Biopharmaceutical Co., Ltd. is located in Banan District, Chongqing, and was established on October 20, 2015. The company went public on June 20, 2023. Its main business involves the research, production, and sales of antibody drugs, with 99.92% of its revenue coming from this segment and 0.08% from other supplementary sources [1]. Stock Performance - On September 2, the stock price of Zhixiang Jintai fell by 5.08%, closing at 35.14 CNY per share. The trading volume was 2.21 billion CNY, with a turnover rate of 5.26%. The total market capitalization is 12.885 billion CNY [1]. Fund Holdings - A fund under Bank of China Securities holds a significant position in Zhixiang Jintai. The Bank of China Health Industry Mixed Fund (002938) held 255,000 shares in the second quarter, accounting for 4.48% of the fund's net value, making it the eighth largest holding. The estimated floating loss today is approximately 479,400 CNY [2]. Fund Performance - The Bank of China Health Industry Mixed Fund was established on September 7, 2016, with a current size of 158 million CNY. Year-to-date, it has achieved a return of 71.3%, ranking 267 out of 8,184 in its category. Over the past year, the return is 78.36%, ranking 889 out of 7,971. Since inception, the fund has returned 187.73% [2].